Zhongyi Lu joined Vivo with a background in private equity and investment banking. Prior to joining Vivo, he worked in private equity starting in 2015, at EQT and CITIC Xinjin, focused on cross-border buy-out investments and portfolio management in healthcare and consumer sectors. Before private equity, he worked in investment banking at Nomura, HSBC, and CEC Capital.
Zhongyi received B.S. in Chemistry from the California Institute of Technology, M.S. in Biotechnology from the Johns Hopkins University, and MBA from the Wharton School of the University of Pennsylvania. He was a trainee at the Medical Scientist Training Program of the University of Washington School of Medicine before his career in investment banking and private equity.